Cargando…
Clinical efficacy of Shankhapushpi and a herbo-mineral compound in type-II diabetes
Diabetic population is more than 245 million worldwide and expected to be b380 million by 2025. One of the main causes of increasing rate of diabetes is stress and tension in day-to-day life, disturbing the homeostasis of positive and negative emotions to initiate pathophysiology of stress-induced d...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3611639/ https://www.ncbi.nlm.nih.gov/pubmed/23559795 http://dx.doi.org/10.4103/0974-8520.105243 |
_version_ | 1782264552807727104 |
---|---|
author | Patel, Dhananjay V. Chandola, Harimohan Baghel, Madhav Singh Joshi, Jayesh R. |
author_facet | Patel, Dhananjay V. Chandola, Harimohan Baghel, Madhav Singh Joshi, Jayesh R. |
author_sort | Patel, Dhananjay V. |
collection | PubMed |
description | Diabetic population is more than 245 million worldwide and expected to be b380 million by 2025. One of the main causes of increasing rate of diabetes is stress and tension in day-to-day life, disturbing the homeostasis of positive and negative emotions to initiate pathophysiology of stress-induced diabetes. In the present study, in Group A of 34 patients, a herbo-mineral compound containing Shuddha Shilajatu, Shuddha Guggulu, Vijayasara Ghana, Saptarangi Ghana, and Triphala Ghana was administered in the dose of 3 gm/day in three divided doses with luke-warm water before meal for the duration of 8 weeks, which significantly relieved symptoms (60.52%) like Prabhuta Mutrata (54.55%), Avila Mutrata (66.67%), Daurbalya (61.36%), Shrama (59.32%), etc. with fasting blood sugar (4.05%) and postprandial blood sugar (9.95%). In another series of 34 patients (Group B), where psychological health promoting drug Shankhapushpi was administered in the dose of 1.5 gm/day in three divided doses for 8 weeks along with herbo-mineral compound. The percentage relief was found to be more better on symptoms (71.13%) like Prabhuta Mutrata (76.92%), Avila Mutrata (83.33%), Daurbalya (75%), Shrama (70.37%), fasting blood sugar (18.04%) and postprandial blood sugar (27.75%). Group B showed better results on psychological parameters like disturbed Manasabhava (29.16%) and Brief Psychiatry Rating Scale (38.28%). The high significance of χ(2) (15.50) on overall effect of therapy indicated better results in group B. |
format | Online Article Text |
id | pubmed-3611639 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-36116392013-04-04 Clinical efficacy of Shankhapushpi and a herbo-mineral compound in type-II diabetes Patel, Dhananjay V. Chandola, Harimohan Baghel, Madhav Singh Joshi, Jayesh R. Ayu Clinical Research Diabetic population is more than 245 million worldwide and expected to be b380 million by 2025. One of the main causes of increasing rate of diabetes is stress and tension in day-to-day life, disturbing the homeostasis of positive and negative emotions to initiate pathophysiology of stress-induced diabetes. In the present study, in Group A of 34 patients, a herbo-mineral compound containing Shuddha Shilajatu, Shuddha Guggulu, Vijayasara Ghana, Saptarangi Ghana, and Triphala Ghana was administered in the dose of 3 gm/day in three divided doses with luke-warm water before meal for the duration of 8 weeks, which significantly relieved symptoms (60.52%) like Prabhuta Mutrata (54.55%), Avila Mutrata (66.67%), Daurbalya (61.36%), Shrama (59.32%), etc. with fasting blood sugar (4.05%) and postprandial blood sugar (9.95%). In another series of 34 patients (Group B), where psychological health promoting drug Shankhapushpi was administered in the dose of 1.5 gm/day in three divided doses for 8 weeks along with herbo-mineral compound. The percentage relief was found to be more better on symptoms (71.13%) like Prabhuta Mutrata (76.92%), Avila Mutrata (83.33%), Daurbalya (75%), Shrama (70.37%), fasting blood sugar (18.04%) and postprandial blood sugar (27.75%). Group B showed better results on psychological parameters like disturbed Manasabhava (29.16%) and Brief Psychiatry Rating Scale (38.28%). The high significance of χ(2) (15.50) on overall effect of therapy indicated better results in group B. Medknow Publications & Media Pvt Ltd 2012 /pmc/articles/PMC3611639/ /pubmed/23559795 http://dx.doi.org/10.4103/0974-8520.105243 Text en Copyright: © AYU (An International Quarterly Journal of Research in Ayurveda) http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Clinical Research Patel, Dhananjay V. Chandola, Harimohan Baghel, Madhav Singh Joshi, Jayesh R. Clinical efficacy of Shankhapushpi and a herbo-mineral compound in type-II diabetes |
title | Clinical efficacy of Shankhapushpi and a herbo-mineral compound in type-II diabetes |
title_full | Clinical efficacy of Shankhapushpi and a herbo-mineral compound in type-II diabetes |
title_fullStr | Clinical efficacy of Shankhapushpi and a herbo-mineral compound in type-II diabetes |
title_full_unstemmed | Clinical efficacy of Shankhapushpi and a herbo-mineral compound in type-II diabetes |
title_short | Clinical efficacy of Shankhapushpi and a herbo-mineral compound in type-II diabetes |
title_sort | clinical efficacy of shankhapushpi and a herbo-mineral compound in type-ii diabetes |
topic | Clinical Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3611639/ https://www.ncbi.nlm.nih.gov/pubmed/23559795 http://dx.doi.org/10.4103/0974-8520.105243 |
work_keys_str_mv | AT pateldhananjayv clinicalefficacyofshankhapushpiandaherbomineralcompoundintypeiidiabetes AT chandolaharimohan clinicalefficacyofshankhapushpiandaherbomineralcompoundintypeiidiabetes AT baghelmadhavsingh clinicalefficacyofshankhapushpiandaherbomineralcompoundintypeiidiabetes AT joshijayeshr clinicalefficacyofshankhapushpiandaherbomineralcompoundintypeiidiabetes |